Molecular Building Blocks: How Modified Nucleotides Are Powering mRNA Therapeutics
The Pseudouridine Market is experiencing robust growth as modified nucleotides continue to power mRNA therapeutics and vaccine development. According to market reports, the global Pseudouridine Market was valued at USD 500 million in 2024 and is projected to reach USD 1.5 billion by 2035, exhibiting a CAGR of 10.6% during the forecast period. This impressive growth reflects the...
0 Comments 0 Shares 241 Views 0 Reviews